The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review-Reference-Cited by-同舟云学术

The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review

Published:2017-11-24 Issue:2 Volume:54 Page:282-294
ISSN:1080-0549
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Yao Mingjie,Wang Leijie,Leung Patrick S. C.,Li Yanmei,Liu Shuhong,Wang Lu,Guo Xiaodong,Zhou Guangde,Yan Ying,Guan Guiwen,Chen Xiangmei,Bowlus Christopher L.,Liu Tianhui,Jia Jidong,Gershwin M. Eric,Ma Xiong,Zhao Jingmin,Lu Fengmin

Funder

National S & T Major Project for Infectious Diseases

Beijing Municipal Science and Technology Commission

National Natural Science Foundation of China

111 Project

Research Found of Capital Medical Development

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s12016-017-8655-y/fulltext.html

Reference77 articles.

1. Ganem D, Prince AM (2004) Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 350(11):1118–1129. https://doi.org/10.1056/NEJMra031087

2. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45(2):507–539. https://doi.org/10.1002/hep.21513

3. Thein HH, Yi Q, Dore GJ, Krahn MD (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 48(2):418–431. https://doi.org/10.1002/hep.22375

4. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 7(8):448–458. https://doi.org/10.1038/nrgastro.2010.100

5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55(6):2005–2023. https://doi.org/10.1002/hep.25762

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Biosensor Technology for Early-Stage Detection of Hepatocellular Carcinoma-Specific Biomarkers: An Overview;Diagnostics;2024-07-15

2. Biomarcadores séricos para la evaluación de la fibrosis hepática;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2024-02-14

3. Golgi Protein 73 Promotes Angiogenesis in Hepatocellular Carcinoma;Research;2024-01

4. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis;Journal of Medical Virology;2024-01

5. The Golgi Apparatus as an Anticancer Therapeutic Target;Biology;2023-12-19